维普期刊资源整合服务平台（V6.5）

99篇 您的检索式：作者名="schorge JO"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Bcl-2andp53protein expression,apoptosis and p53 mutation inhuman epithelial ovarian cancers显示文摘	Chan WY Cheung KK Schorge JO	2000	Am J Pathol2000，156，：	1
2	Osteopontin as an ad-junct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	ClinCancer Res2004，10，10：	1
3	Bcl-2 and p53 Protein Expression,Apoptosis,and p53 Mutation in Human Epithelial Ovarian Cancers显示文摘	Chan WY Cheung KK Schorge JO	2000	Am J Pathol2000，156，：	1
4	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	Clin Cancer Res2004，10，10：	1
5	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	Clin Cancer Res2004，10，10：	1
6	Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers显示文摘	Chan WY Chetmg KK Schorge JO	2000	Am J Pathol2000，156，2：	1
7	Recent advances in gestational trophoblastic disease 显示文摘	Schorge JO Goldstein DP Bemstein MR	2000	J Reprod Med2000，45，9：	1
8	Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer显示文摘	Schorge JO Drake RD Lee H	2004	Clin Cancer Res2004，10，10：	1
9	Secondary cytoreductive surgery for recurrent platinum sensitive ovarian cancer显示文摘	Schorge JO Wingo SN Bhore R	2010	Int J Gynaecol Obstet2010，1118，2：	1
10	Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data 显示文摘	Vlahou A Schorge JO Gregory BW	2003	J Biomed Biotechnol2003，2003，5：	1
11	Cytoreductive surgery for ad- vanced ovarian cancer: quo vadis? 显示文摘	Schorge JO Garrett LA Goodman A	2011	Oncology2011，25，10：	1
12	Multimodalitytherapy in early-stage neuroendocrine carcinoma of the uterinecervix显示文摘	Boruta DM 2nd Schorge JO Duska LA	2001	Gynecol Oncol2001，81，1：	1
13	Prospective management of stage IA(1)cervical adenocarcinoma by conization alone to preserve fertility:a preliminary report显示文摘	Schorge JO Lee KR Sheets EE	2000	Gynecol Oncol2000，78，2：	1
14	Stage IA1 cervical adenocarcin-oma:definition and treatment显示文摘	Schorge JO Lee KR Flynn CE	1999	Obstet Gynecol1999，93，2：	1
15	Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer 显示文摘	Curley MD Garrett LA Schorge JO	2011	Front Biosei2011，16，：	1
16	Prospective deter- mination of prevalence of lynch syndrome in yong women with en- dometrial cancer 显示文摘	Lu KH Schorge JO Rodabaugh K J	2007	J Clin Oncol2007，25，33：	1
17	Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women显示文摘	Rathi A Virmani AK Schorge JO	2002	Clin Cancer Res2002，8，11：	1
18	Prospective management of stage IA cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report显示文摘	Schorge JO Lee KR Sheets EE	2000	Gynecol Oncol2000，78，：	1
19	SGO White Paper on ovarian Cancer: etiology, screening and surveil- lance显示文摘	Schorge JO Modesitt SC Coleman RL	2010	Gynecol Oncol2010，119，1：	1
20	Prospective management of stage IA cervical adenocarcinoma by conization alone to preserve fertility : a preliminary report 显示文摘	Schorge JO Lee KR Sheets EE	2000	Gynecol Oncol2000，78，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示